EL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Estee Lauder Companies Inc (EL) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock is currently in a downtrend with weak technical indicators, insider selling, and mixed analyst sentiment. While the company has positive catalysts like the Forest Essentials acquisition and improved gross margins, its declining net income and EPS, along with muted growth expectations, suggest waiting for clearer signs of recovery before investing.
The stock is in a bearish trend. The MACD histogram is negative and expanding, indicating downward momentum. The RSI is at 18.082, signaling oversold conditions, but this does not necessarily indicate an immediate reversal. Moving averages are converging, showing indecision. The stock is trading near its S1 support level of 97.839, with further downside risk toward S2 at 92.483.
Acquisition of Forest Essentials, which enhances Estee Lauder's presence in the global beauty market.
Gross margin improvement to 76.5%, reflecting operational efficiency.
Some analysts view the recent selloff as a buying opportunity, citing improved fundamentals under the new CEO's strategy.
Insider selling has increased significantly, indicating potential lack of confidence from within the company.
Net income and EPS have dropped significantly YoY, signaling profitability challenges.
Analysts have downgraded the stock or lowered price targets, citing muted growth expectations and tough comparables in key markets like China.
Weak technical indicators and bearish sentiment in options data.
In Q2 2026, revenue grew by 5.62% YoY to $4.229 billion, but net income dropped by -127.46% YoY to $162 million. EPS also fell by -126.83% YoY to $0.44. Gross margin improved slightly to 76.5%, up 0.53% YoY. The financials indicate revenue growth but significant profitability challenges.
Analyst sentiment is mixed. While some firms like Citi and JPMorgan see the recent selloff as a buying opportunity, others like HSBC, TD Cowen, and Barclays have downgraded the stock or lowered price targets, citing muted growth expectations and tough comparables. Price targets range from $94 to $140, with a median around $105, slightly above the current price.
